| Website | uniseed.com.au |
| Phone | 61-7-3365-6937 |
| Employees | |
| Founded | 2000 |
| Description | Seeding university technology ventures |
Uniseed began as a $20 million venture fund, founded by the Universities of Queensland and Melbourne. Since then, through investment commitment from Westscheme, Western Australia’s largest non-government superannuation fund, the University of New South Wales and further investment from the founding Universities, the fund has grown to over $60 million.
Uniseed has a commitment to successfully commercialise the outcomes of Australian research and ingenuity from the University of Queensland, the University of Melbourne and the University of New South Wales.
It represents an important step in forging a link between academia and business that focuses on the commercialisation of innovative ideas and inventions for global consumption.
Uniseed has strong capabilities to package research outcomes from the academic research environment.
| Company | Date | Round | Size | Participants |
| Hatchtech | 5/12 | Venture Round | $8.1M | 3 |
| Spinifex Pharmaceuticals | 8/11 | Series B | $19M | 3 |
| BT Imaging | 8/10 | Series A | $3.8M | 3 |
| Manjrasoft | 12/09 | Venture Round | $529k | 1 |
| BT Imaging | 6/08 | Series A | $2.86M | 2 |
| Fultec Semiconductor | 3/06 | Series C | $12.4M | 5 |
| OPAL Therapeutics | 10/05 | Series A | $6M | 4 |
| Hatchtech | 5/05 | Venture Round | $2.2M | 5 |
